NEWS

Cromos Pharma’s CEO Dr. Vlad Bogin has joined the board of directors of Batu Biologics Cromos Pharma’s CEO Dr. Vlad Bogin has joined the board of directors of Batu Biologics, a biotechnology-based pharmaceutical company focused on the development and commercialization of novel ‎cancer treatments.

Cromos Pharma’s country head in Georgia gives narrative on clinical trials to Rustavi 2 TV channel

Cromos™ Pharma launches risk-sharing partnerships program with biotech and pharma companies

As the debate about “strategic” vs. “transactional” relationship between Pharma and CROs goes on, we thought that you might enjoy a viewpoint of an independent regional player As the debate about “strategic” vs. “transactional” relationship between Pharma and CROs goes on, we thought that you might enjoy a viewpoint of an independent regional player. Please follow the link to the whitepaper that may provide some additional insight into this contentious issue.

CLINICAL TRIALS AND RESEARCH IN ISRAEL BEIT-DAGAN, ISRAЕL–(Marketwired – Jan 15, 2014) – Cromos Pharma, a premier regional contract research organization (CRO), announced today that it started clinical trial operations in the State of Israel. “Israel is at the forefront of medical innovation,” said Dr. Vlad Bogin, Cromos Pharma’s CEO. “We are very excited to enter its market and view this

Dr. Vlad Bogin, Cromos Pharma’s CEO authors an article titled “All Global Clinical Trials Are Local” in the Journal of Clinical Research Best Practices